SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis

202237 citationsReview

Authors

SGLT-2 inhibitors improved CV outcomes irrespective of heart failure history or type, and severity of LVEF reduction.

Good health and well-being

Published in: European Heart Journal - Cardiovascular Pharmacotherapy

Volume 8, Issue 6, pp. 557-567

Field-Weighted Citation Impact: 5.16